Graft-Versus-Host Disease Archives - Express Pharma

Eugia Pharma gets USFDA nod for posaconazole injection, 300 mg/16.7 mL, single-dose vial

Markets for GvHD in five APAC markets to grow at 8.2 per cent CAGR in 10 years: GlobalData

Global GVHD treatment market will thrive, reaching $545 million by 2023